Log In
BCIQ
Print this Print this
 

Clevegen (FP-1302)

  Manage Alerts
Collapse Summary General Information
Company Faron Pharmaceuticals Oy
DescriptionHuman antibody against stabilin 1 (STAB1; CLEVER-1; FEEL-1)
Molecular Target Stabilin 1 (STAB1) (CLEVER-1) (FEEL-1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
PartnerTurku PET Centre

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/30/2015

Undisclosed

0

0

Get a free BioCentury trial today